Jim Cramer Highlights Massive Gains for Terns Pharmaceuticals Shareholders
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the stocks Jim Cramer was asked about. Inquiring about the stock, a caller mentioned that they purchased it at approximately 2 before surging to around 1.2 billion. You have won the lottery. You do not need to win it again. Here’s the sound. It tells you everything [kaching-kaching].” Stock market data showing ...